State Street’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.68M | Buy |
|
|||||
|
2025
Q2 | $4.06M | Buy |
|
|||||
|
2025
Q1 | $2.14M | Sell |
|
|||||
|
2024
Q4 | $2.38M | Sell |
|
|||||
|
2024
Q3 | $8.4M | Sell |
|
|||||
|
2024
Q2 | $21.4M | Sell |
|
|||||
|
2024
Q1 | $65M | Buy |
|
|||||
|
2023
Q4 | $51.4M | Sell |
|
|||||
|
2023
Q3 | $45M | Sell |
|
|||||
|
2023
Q2 | $54.7M | Sell |
|
|||||
|
2023
Q1 | $59.2M | Sell |
|
|||||
|
2022
Q4 | $81.8M | Buy |
|
|||||
|
2022
Q3 | $77.7M | Sell |
|
|||||
|
2022
Q2 | $93.2M | Buy |
|
|||||
|
2022
Q1 | $104M | Buy |
|
|||||
|
2021
Q4 | $86.9M | Buy |
|
|||||
|
2021
Q3 | $88.7M | Sell |
|
|||||
|
2021
Q2 | $144M | Buy |
|
|||||
|
2021
Q1 | $97.6M | Buy |
|
|||||
|
2020
Q4 | $159M | Sell |
|
|||||
|
2020
Q3 | $81.6M | Sell |
|
|||||
|
2020
Q2 | $91.2M | Buy |
|
|||||
|
2020
Q1 | $40.2M | Buy |
|
|||||
|
2019
Q4 | $58.9M | Sell |
|
|||||
|
2019
Q3 | $49.7M | Sell |
|
|||||
|
2019
Q2 | $68.2M | Sell |
|
|||||
|
2019
Q1 | $69.8M | Buy |
|
|||||
|
2018
Q4 | $49M | Sell |
|
|||||
|
2018
Q3 | $93M | Buy |
|
|||||
|
2018
Q2 | $93M | Buy |
|
|||||
|
2018
Q1 | $79.4M | Sell |
|
|||||
|
2017
Q4 | $73.9M | Buy |
|
|||||
|
2017
Q3 | $44.5M | Buy |
|
|||||
|
2017
Q2 | $9.02M | Buy |
|
|||||
|
2017
Q1 | $2.96M | Buy |
|
|||||
|
2016
Q4 | $1.71M | Buy |
|
|||||
|
2016
Q3 | $1.38M | Buy |
|
|||||
|
2016
Q2 | $2.45M | Buy |
|
|||||
|
2016
Q1 | $1.19M | Buy |
|